- Home
- LFWD vs BRTX Comparison
LFWD vs BRTX Comparison
Compare LFWD & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFWD
- BRTX
- Stock Information
- Founded
- LFWD 2001
- BRTX 1997
- Country
- LFWD Israel
- BRTX United States
- Employees
- LFWD N/A
- BRTX N/A
- Industry
- LFWD
- BRTX Managed Health Care
- Sector
- LFWD
- BRTX Health Care
- Exchange
- LFWD NYSE
- BRTX Nasdaq
- Market Cap
- LFWD 13.7M
- BRTX 13.6M
- IPO Year
- LFWD 2014
- BRTX N/A
- Fundamental
- Price
- LFWD $1.54
- BRTX $2.33
- Analyst Decision
- LFWD Strong Buy
- BRTX Strong Buy
- Analyst Count
- LFWD 1
- BRTX 1
- Target Price
- LFWD $13.00
- BRTX $18.00
- AVG Volume (30 Days)
- LFWD 696.5K
- BRTX 55.0K
- Earning Date
- LFWD 02-25-2025
- BRTX 11-12-2024
- Dividend Yield
- LFWD N/A
- BRTX N/A
- EPS Growth
- LFWD N/A
- BRTX N/A
- EPS
- LFWD N/A
- BRTX N/A
- Revenue
- LFWD $25,002,000.00
- BRTX $377,000.00
- Revenue This Year
- LFWD $87.01
- BRTX $482.76
- Revenue Next Year
- LFWD $47.64
- BRTX $212.24
- P/E Ratio
- LFWD N/A
- BRTX N/A
- Revenue Growth
- LFWD 173.28
- BRTX 189.55
- 52 Week Low
- LFWD $1.41
- BRTX $1.03
- 52 Week High
- LFWD $7.84
- BRTX $3.67
- Technical
- Relative Strength Index (RSI)
- LFWD 43.19
- BRTX 74.26
- Support Level
- LFWD $1.83
- BRTX $1.75
- Resistance Level
- LFWD $4.00
- BRTX $2.40
- Average True Range (ATR)
- LFWD 0.35
- BRTX 0.18
- MACD
- LFWD -0.05
- BRTX 0.07
- Stochastic Oscillator
- LFWD 2.75
- BRTX 89.58
About LFWD REWALK ROBOTICS LTD
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.